Interestingly, one of the most commonly methylated genes in this study, SEPT9, is the basis for an FDA-approved, methylation-based colorectal cancer detection test (Epi proColon) and is being explored as a biomarker for lung cancer [52], [53]. This evidence concerns the gene SEPTIN9 and lung carcinoma.